The tumor immune estimation resource (TIMER) platform was applied to explore the correlation between infiltration levels of immune cells and the expression of four prognosis-related genes (including NR6A1, CXCL5, TGFB1, and C3). The gene discussed is TGFB1; the disease is neoplasm.